Fiscal Year End Company Status Exempt Flag January 31 Trading N Board of Directors Name Position Ian McConnan  Director of the Board Lorne T. Meikle  Director of the Board Not Applicable (None)  President Paul Van Damme  Director of the Board Ragupathy Madiyalakan  Director of the Board Incorporation Locations Inc. Date Expiry Date Country Region Description 16/Dec/1996    Canada  Alberta  ALBERTA - 12/16/96  Exchange Filing Office Location Calgary Regional Service Office		Business Type(s) Primary/Secondary Business Type Details Primary  Research and Development of Pharmaceutical Products  (not available)  Securities Symbol Security Name Market Status QPT Quest Pharmatech Inc. TSX Venture TRADING Name History From To Quest PharmaTech Inc. 5/Oct/2005 Present Company Facts Reconciliation Subject Date Returned Spring 2012 CFR Not Received Associations Auditing Firm:  Ernst & Young, Chartered Accountants Law Firm:  Miller Thomson LLP Subsidiary:  Steroidogenesis Inhibitors Canada Inc.   Sonolight Pharmaceuticals Corp.   Danamedix Inc.   Altachem Pharma Inc. Transfer Agent:  Computershare Trust Company of Canada
Latest Information Type Date Title News Releases  8/Apr/2013  NEWS RELEASE - QUEST PHARMATECH SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UCLA FOR ANTI - PSA IGE TECHNOLOGY; UCLA RESEARCHERS TO PRESENT ANTI - PSA IGE PRECLINICAL DATA AT THE 2013 AMERICAN ASSOCIATION FOR CANCER RESEARCH CONFERENCE[CANADA NEWSWIRE]     NEWS RELEASE - SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UCLA FOR[MARKET NEWS]     NEWS RELEASE - ENROLLS 40TH PATIENT IN ITS PHASE II OREGOVOMAB[MARKET NEWS] Bulletins  12/Oct/2012  Miscellaneous Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data